Symptoms and General Pathology

All Conditions

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Neoplasms

Gland and Hormone Related Diseases

Syndrome

Infertility

Infertility, Female

Polycystic Ovary Syndrome

Genital Diseases

Urogenital Diseases

Cysts

Ovarian Cysts

Ovarian Diseases

Adnexal Diseases

Genital Diseases, Female

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Gonadal Disorders

Endocrine System Diseases

Patients who have received 25 IU gonadotropin dose increment on 7th day of ovulation induction

Patients who have received 25 IU gonadotropin dose increment on 14th day of ovulation induction

Gonadotropin dose increments of 25 IU will be utilized on 7th and 14th day of ovulation induction for each study group.

Gonadotropin dose increment timing

Serkan Kahyaoglu, M.D

Inci Kahyaoglu, M.D

Omer H Yumusak, M.D

Berna Seckin, M.D

Hacer C Gulerman, M.D

Muzeyyen G Ozaksit, M.D

Ozlem Moraloglu Tekin, M.D

Low dose gonadotropin step-up ovulation induction treatment is the universally accepted and utilized teratment protocol for infertile women diagnosed with polycystic ovary syndrome (PCOS). First dose increment is advised on 14th day of ovarian stimulation with gonadotropins to decrease multiple follicle generation and cycle cancellation rates. However, clinicians impatiently increase gonadotropin dose on 7th day of stimulation without strong scientific evidence. This randomised controlled study will be the first study which will compare safety and ovulation induction cyle outcomes of early and late dose increments among infertile women diagnosed with PCOS.

Low dose gonadotropin step-up ovulation induction treatment is the universally accepted and utilized teratment protocol for infertile women diagnosed with polycystic ovary syndrome. First dose increment is advised on 14th day of ovarian stimulation with gonadotropins to decrease multiple follicle generation and cycle cancellation rates. However, clinicians impatiently increase gonadotropin dose on 7th day of stimulation without strong scientific evidence. This randomised controlled study will be the first study which will compare safety and ovulation induction cyle outcomes of early and late dose increments among infertile women diagnosed with polycystic ovary syndrome.

We will start low dose step-up ovulation induction treatment by using 50 IU recombinant FSH for 21-39 years old non- obese patients (BMI \<30 kg/m2) diagnosed with PCOS and . We will perform folliculometry on 7th day of ovulation induction. In case of absence for at least one \>10 mm dominant follicle, we will randomise these women by using blind envelope selection method for assignment of early or late dose incerement groups. Half of the patients will receive 25 IU dose increment on 7th day of ovulation induction, remaining half will receive dose increment on 14th day of ovulation induction. We will continue ovarian stimulation without any other dose increment until 35th day of stimulation as deadline time restriction. We will perform folliculometry and serum estradiol measurement intermittently during ovulation induction. We will record ovulation induction cycle outcomes and clinical pregnancy results of the study group following finalization for treatment cyle of each patient. We will compare ovulation induction cycle outcomes of these two dose increment groups.

Comparison of Ovulation Induction Cycle Outcomes Between Early and Late Dose Increments for Low Dose Gonadotropin Step-up Protocol Among Infertile Women Diagnosed With Polycystic Ovary Syndrome: Prospective Randomised Trial

Number of \>14 mm sized follicles at the end of the ovulation induction treatment

Serum pregnancy test will be performed 2 weeks after ovulation triggering

Clinical pregnancy rate which will be evaluated 3 weeks after ovulation triggering

Total number of ovulation induction days until ovulation triggering

Cycle cancellation due to \>=3 preovulatory follicles (\>14 mm in size) at the end of the ovulation induction treatment

Multiple pregnancy rate which will be evaluated 3 weeks after ovulation triggering

Saglik Bilimleri Universitesi

Associate Professor, M.D

Anticoagulants

All Drugs and Chemicals

Reproductive Control Agents

Other Dietary Supplements

Citric Acid

Sodium Citrate

Clomiphene

Enclomiphene

Zuclomiphene

Menotropins

Citrate

Women will be subjected to ovarian stimulation for 6 months with the gonadotropin low-dose step-down protocol.

Women will be subjected to ovarian stimulation for 6 months with the gonadotropin low-dose step-down protocol

Gonadotropin

Ahmed Gibreel, Dr

Mohamed S Abdelhafez, Dr

The purpose of this study is to compare the efficacy of in vitro fertilization (IVF) versus gonadotropin therapy in infertile women having clomiphene citrate (CC) resistant polycystic ovarian syndrome (PCOS).

Women will be randomly divided into two groups; IVF group and gonadotropin group. Women in the IVF group will undergo one full IVF cycle. Women in the gonadotropin group will be subjected to ovarian stimulation for 6 months with the gonadotropin low-dose step-down protocol.

IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS

In Vitro Fertilization Versus Gonadotropin Therapy in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome

Number of live births divided by the number of women

Number of clinical pregnancies divided by the number of women

Number of multifetal pregnancies divided by the number of clinical pregnancies

Number of first trimester miscarriages (before 12 weeks gestational age) divided by the number of clinical pregnancies

Incidence of OHSS within 9 days of final triggering of oocyte maturation

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Comparison of Ovulation Induction Cycle Outcomes Between Early and Late Dose Increments for Low Dose Gonadotropin Step-up Protocol Among Infertile Women Diagnosed With Polycystic Ovary Syndrome: Prospective Randomised Trial	NCT04528849	Polycystic Ovar... Infertility, Fe...	Gonadotropin do...	21 Years - 39 Years	Saglik Bilimleri Universitesi
IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS	NCT02458963	Infertility Polycystic Ovar...	IVF Gonadotropin	20 Years - 35 Years	Mansoura University
IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS	NCT02458963	Infertility Polycystic Ovar...	IVF Gonadotropin	20 Years - 35 Years	Mansoura University
Comparison of Ovulation Induction Cycle Outcomes Between Early and Late Dose Increments for Low Dose Gonadotropin Step-up Protocol Among Infertile Women Diagnosed With Polycystic Ovary Syndrome: Prospective Randomised Trial	NCT04528849	Polycystic Ovar... Infertility, Fe...	Gonadotropin do...	21 Years - 39 Years	Saglik Bilimleri Universitesi

Spots Global Cancer Trial Database for gonadotropin

Every month we try and update this database with for gonadotropin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.